| For: | Fan Q, Fu ZW, Xu M, Lv F, Shi JS, Zeng QQ, Xiong DH. Research progress of tumor-associated macrophages in immune checkpoint inhibitor tolerance in colorectal cancer. World J Gastrointest Oncol 2024; 16(10): 4064-4079 [PMID: 39473964 DOI: 10.4251/wjgo.v16.i10.4064] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v16/i10/4064.htm |
| Number | Citing Articles |
| 1 |
Xinyu Cao, Shen Wan, Bingyu Wu, Zhikuan Liu, Lixing Xu, Yu Ding, Haiqin Huang. Antitumor Research Based on Drug Delivery Carriers: Reversing the Polarization of Tumor-Associated Macrophages. Molecular Pharmaceutics 2025; 22(3) doi: 10.1021/acs.molpharmaceut.4c01277
|
| 2 |
Geumseong Yeun, Ik-Hwan Han, Ilseob Choi, Soyoung Kim, Hyojung Choi, Hyunsu Bae. STAT6 inhibition of M2 macrophages suppresses tumor growth by modulating the tumor microenvironment in colon cancer model. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1733991
|
| 3 |
Xiaoming Yu, Xinyi Wu. Exosomal let-7b-5p derived from Aspergillus fumigatus-treated human corneal epithelial cells promotes M1 macrophage activation via targeting SOCS-1. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1548802
|